These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27745574)

  • 61. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lactulose: A Simple Sugar in a Complex Encephalopathy.
    Wijdicks EFM
    Neurocrit Care; 2018 Apr; 28(2):154-156. PubMed ID: 29297141
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Subclinical hepatic encephalopathy].
    Jia L; Li Y
    Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):495-7. PubMed ID: 9592321
    [No Abstract]   [Full Text] [Related]  

  • 64. Lactulose or lactose in hepatic encephalopathy?
    Desai HG
    Indian J Gastroenterol; 1983 Apr; 2(1):7. PubMed ID: 6565636
    [No Abstract]   [Full Text] [Related]  

  • 65. [Treatment of hepatic encephalopathy with lactulose].
    Veljkov N; Kulenović S; Borovac N; Rezaković D
    Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
    [No Abstract]   [Full Text] [Related]  

  • 66. Lactulose enemas in the treatment of hepatic encephalopathy. Do we help or harm?
    de Lorenzo-Pinto A; García-Sánchez R; Lorenzo-Salinas A
    Rev Esp Enferm Dig; 2017 Oct; 109(10):736-737. PubMed ID: 28929776
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Successful use of vancomycin hydrochloride in the treatment of lactulose-resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():284-6. PubMed ID: 2519078
    [No Abstract]   [Full Text] [Related]  

  • 69. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Said VJ; Garcia-Trujillo E
    Gastroenterol Nurs; 2019; 42(3):277-285. PubMed ID: 31145253
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The use of lactulose in portal-systemic encephalopathy.
    Matthews SJ
    Conn Med; 1978 Feb; 42(2):96-7. PubMed ID: 630868
    [No Abstract]   [Full Text] [Related]  

  • 72. Durability of rifaximin response in hepatic encephalopathy.
    Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
    J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A possible case of minimal hepatic encephalopathy treated successfully with lactulose.
    Spiegel DR; Surkin K
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E1. PubMed ID: 21304108
    [No Abstract]   [Full Text] [Related]  

  • 74. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
    Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
    [No Abstract]   [Full Text] [Related]  

  • 76. Sodium benzoate and lactulose for the treatment of hepatic encephalopathy.
    Campollo O; Cortéz R; Gutiérrez M; Odor A; Muñoz RM
    J Hepatol; 1994 Dec; 21(6):1144. PubMed ID: 7699242
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacoeconomics of hepatic encephalopathy.
    Neff G
    Pharmacotherapy; 2010 May; 30(5 Pt 2):28S-32S. PubMed ID: 20412038
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 79. Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases.
    Juttijudata P; Meensook C
    J Med Assoc Thai; 1981 Dec; 64(12):636-9. PubMed ID: 6153032
    [No Abstract]   [Full Text] [Related]  

  • 80. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.